Literature DB >> 23007326

Splenic marginal zone lymphoma in a HIV-1 infected patient: evidence favouring a pathogenetic role of HIV-1 itself in the lymphomagenesis.

M Cagliuso1, V Conti, S Trasarti, L Lombardi, M Riminucci, M Perez, O Turriziani, F Falasca, M Nanni, A Tafuri, I Mezzaroma.   

Abstract

A rare case of splenic marginal zone lymphoma (SMZL) in a human immunodeficiency virus (HIV)-1 infected patient is described. As an association between SMZL and viral infections has been reported, the presence of the hepatitis C virus and HIV-1 genomes was evaluated. Only HIV-1 DNA levels were detected in enriched splenic B lymphocytes, suggesting a HIV-1 involvement in lymphomagenesis.

Entities:  

Mesh：

Year:  2012        PMID： 23007326     DOI： 10.1007/s15010-012-0344-4

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


  12 in total

Review 1.  AIDS-related lymphoproliferative disease.

Authors:  Willis H Navarro; Lawrence D Kaplan
Journal:  Blood       Date:  2005-08-11       Impact factor: 22.113

2.  Successful treatment of marginal zone lymphoma with splenectomy alone despite HIV infection.

Authors:  Antonette Withehead; Ariela Noy
Journal:  AIDS       Date:  2007-07-31       Impact factor: 4.177

3.  Splenic marginal zone B-cell lymphoma in a HIV-positive patient: a case report.

Authors:  Luca Arcaini; Paolo Sacchi; Vassili Jemos; Marco Lucioni; Elisa Rumi; Paolo Dionigi; Marco Paulli
Journal:  Ann Hematol       Date:  2008-08-16       Impact factor: 3.673

4.  Molecular and virologic characteristics of lymphoid malignancies in children with AIDS.

Authors:  K L McClain; C T Leach; H B Jenson; V V Joshi; B H Pollock; R E Hutchison; S B Murphy
Journal:  J Acquir Immune Defic Syndr       Date:  2000-02-01       Impact factor: 3.731

Review 5.  Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification.

Authors:  A Traverse-Glehen; L Baseggio; G Salles; P Felman; F Berger
Journal:  Curr Opin Oncol       Date:  2011-09       Impact factor: 3.645

6.  AIDS-related bone marrow lesions--myelodysplastic features or predominant inflammatory-reactive changes (HIV-myelopathy)? A comparative morphometric study by immunohistochemistry with special emphasis on apoptosis and PCNA-labeling.

Authors:  J Thiele; T K Zirbes; H P Bertsch; B R Titius; J Lorenzen; R Fischer
Journal:  Anal Cell Pathol       Date:  1996-08       Impact factor: 2.916

7.  Expression of the human immunodeficiency virus-Tat gene in lymphoid tissues of transgenic mice is associated with B-cell lymphoma.

Authors:  R K Kundu; F Sangiorgi; L Y Wu; P K Pattengale; D R Hinton; P S Gill; R Maxson
Journal:  Blood       Date:  1999-07-01       Impact factor: 22.113

8.  A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades.

Authors:  Yasuhito Tanaka; Kousuke Hanada; Masashi Mizokami; Anthony E T Yeo; J Wai-Kuo Shih; Takashi Gojobori; Harvey J Alter
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-18       Impact factor: 11.205

9.  Characteristics of indolent non-Hodgkin lymphoma in patients with type 1 human immunodeficiency virus infection.

Authors:  Alexandra M Levine; Saeed Sadeghi; Byron Espina; Anil Tulpule; Bharat Nathwani
Journal:  Cancer       Date:  2002-03-01       Impact factor: 6.860

10.  Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells.

Authors:  Cinzia Giagulli; Stefania Marsico; Anna K Magiera; Rosalinda Bruno; Francesca Caccuri; Ines Barone; Simona Fiorentini; Sebastiano Andò; Arnaldo Caruso
Journal:  PLoS One       Date:  2011-03-14       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.